Patient P-02068

Synthetic patientMETA-24 · Day 124 · 75+ · M · baseline S14Steering view · 3D Open companion preview

Therapy response

Improving

Tolerance

Deteriorating

GI state

Favorable

Inflammatory state

Favorable

Nutritional resilience

Favorable

Discontinuation risk

15%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events

solid = observed · dashed = predicted

Day 0 META-24 started — Baseline state S14
Day 26 Trajectory diverged from prediction — Observed response fell below the model's expected path.
Day 30 NP-02 recommended — Dietary Support Protocol NP-02
Day 31 Patient accepted — Started NP-02 in the companion
Day 41 GI symptom burden −12% vs expected — Dietary Support Protocol NP-02
Day 47 Tolerance state changed — Unstable → Improving

What changed?

Trajectory began diverging from predicted response on Day 26.

Primary contributors, last 14 days

Toxicity+7
GI instability-3
Nutritional resilience+3

What helped?

Dietary Support Protocol NP-02Day 30
Result: symptom burden −12%

LIFE OS recommendation

No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

Active minutes

Wearable

37 min

improving · +2.4 vs previous 14 d

Sleep duration

Wearable

8.9 h

stable · +0.2 vs previous 14 d

Energy level

Daily log

8.3/10

improving · +0.8 vs previous 14 d

Steps

Wearable

4,297

improving · +249 vs previous 14 d

GI burden

Companion

6.6/100

improving · -7.2 vs previous 14 d

Adherence

Companion

92.5 %

stable · +1.8 vs previous 14 d

Sleep quality

Wearable

89.4/100

improving · +3.4 vs previous 14 d

Glucose, CGM daily mean

CGM

120 mg/dL

stable · -1.4 vs previous 14 d

This trajectory is decaying — what would help, what would not

Steering view →

Heading towards restoration · 100 from the failing basin, 14 from restoration.

Would help

No untried action with strong evidence. Compose one from primitives.
More protein
GI -7.1 next day on high-intake days · n 24

Would not help

Nothing clearly counter-productive in the record.

State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

Protein
-7.1supporter · 95%
Simple carbohydrates
+1.2no signal · 18%
Caffeine
-0.9no signal · 15%
Histamine load
-0.8no signal · 15%
Alcohol
+0.8no signal · 15%
Ultra-processed food
-0.4no signal · 15%
Dietary fat load
+0.1no signal · 15%
Insoluble fibre
-0.1no signal · 15%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure

Inflammatory signalling ↓20
- MicrobiomeBacteroides fragilis expansion

DNA

Fictional pharmacogenomic panel

CYP2D6 Normal metabolizer
Expected exposure
GLP1R rs6923761 A
Altered receptor sensitivity

Microbiome

Shannon diversity 4.2 · butyrate capacity 79/100

Akkermansia muciniphilaNormal
Faecalibacterium prausnitziiNormal
Bacteroides fragilisHigh
Bifidobacterium longumLow
EnterobacteriaceaeHigh

Wearable, last 14 days

daily evolution fed into the runtime

HRV: 65 ms
Sleep: 8.3 h
Steps: 4,060
Resting HR: 71 bpm

Daily log: GI score 7, nutritional resilience 73, adherence 93.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview

What to eat

Keep meals regular; three to four moderate portions spaced through the day
Include a cooked vegetable portion with each main meal
Keep fibre steady; no new sources this week
Eat slowly and stop at comfortable fullness — smaller volume, more often

What to do

Log the daily check-in; one line is enough
A 15-minute walk after lunch
Keep the sleep window steady
Keep hydration steady: small amounts through the day rather than large volumes at once

What to take

Take the dose at the same time relative to your evening meal
No additional supplements this week
Fictional demo item: continue vitamin D as before

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

Patient	Similarity	Baseline	Intervention	Outcome	Response today
P-02277	42%	S05	AD-05	improved	92
P-02555	41%	S01	AD-05	no change	79
P-02282	37%	S01	BR-03	no change	88
P-02013	36%	S14	BR-03	no change	94
P-02193	33%	S11	CR-01	improved	87
P-02565	40%	S09	DT-01	no change	79
P-02337	38%	S18	DT-01	no change	100
P-02081	36%	S20	DT-01	no change	88
P-02249	36%	S09	DT-01	improved	100
P-02218	30%	S01	DT-01	improved	61
P-02462	30%	S12	DT-01	improved	65
P-02518	29%	S17	DT-01	improved	68